Zelira Therapeutics Limited Profit Margin

The latest profit margin for ZLDAF is -42043.32% as of June 2025. That compares with -951.18% in the prior-year period — down 4320.1% year over year. That is below the Healthcare sector average of 10.58%. Investors often review this figure alongside Zelira Therapeutics Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, ZLDAF's profit margin moved from -951.18% to -42043.32% — a 4320.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Zelira Therapeutics Limited's valuation or profitability profile.

Against Healthcare companies, ZLDAF currently prints -42043.32% for profit margin, while the sector average sits near 10.58%. That is roughly 397467.2% below the sector mean. Large gaps often invite a closer look at Zelira Therapeutics Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Zelira Therapeutics Limited converts resources into returns. At -42043.32%, ZLDAF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -951.18% in the prior-year period — down 4320.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ZLDAF's profit margin (-42043.32%), review year-over-year change from -951.18%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.